Gastón Soria

Gastón has a degree in Genetics and a PhD in Cell Biology from Instituto Leloir and the University of Buenos Aires, including a research internship at the Erasmus Medical Center in the Netherlands. He returned to Argentina in 2012 after conducting his postdoctoral training at the Institut Curie in Paris. Together, these experiences account for 13 years of training in different aspects of cancer research, with focus on DNA replication, DNA repair and epigenetics.

In 2013, Gastón took a position as Assistant Professor & Researcher in the National University of Córdoba and in 2014 he formed his own team for translational cancer research. His group aims to develop phenotypic screening platforms to identify novel targets and drugs for cancer therapy that work through the principle of synthetic lethality. In the past 5 years, his group has established important research agreements with pharmaceutical companies such as GlaxoSmithKline, which led to fundraising, joint publications and bidirectional MTAs and technology licensing. In 2020, a part of Gastón’s group moved to FPM, a high-complexity diagnostics Lab, to start a project on precision oncology through the development of screening assays using patient-derived cancer cells, which lay the foundations for OncoPrecision.